Causal Machine Learning for Cost-Effective Allocation of Development Aid
Kuzmanovic, Milan, Frauen, Dennis, Hatt, Tobias, Feuerriegel, Stefan
–arXiv.org Artificial Intelligence
The Sustainable Development Goals (SDGs) of the United Nations provide a blueprint of a better future by 'leaving no one behind', and, to achieve the SDGs by 2030, poor countries require immense volumes of development aid. In this paper, we develop a causal machine learning framework for predicting heterogeneous treatment effects of aid disbursements to inform effective aid allocation. Specifically, our framework comprises three components: (i) a balancing autoencoder that uses representation learning to embed high-dimensional country characteristics while addressing treatment selection bias; (ii) a counterfactual generator to compute counterfactual outcomes for varying aid volumes to address small sample-size settings; and (iii) an inference model that is used to predict heterogeneous treatment-response curves. We demonstrate the effectiveness of our framework using data with official development aid earmarked to end HIV/AIDS in 105 countries, amounting to more than USD 5.2 billion. For this, we first show that our framework successfully computes heterogeneous treatment-response curves using semi-synthetic data. Then, we demonstrate our framework using real-world HIV data. Our framework points to large opportunities for a more effective aid allocation, suggesting that the total number of new HIV infections could be reduced by up to 3.3% (~50,000 cases) compared to the current allocation practice.
arXiv.org Artificial Intelligence
Jan-31-2024
- Country:
- Africa
- Togo (0.04)
- Lesotho (0.04)
- Mali (0.04)
- Sierra Leone (0.04)
- Burkina Faso (0.04)
- Ethiopia (0.04)
- Niger (0.04)
- Sudan (0.04)
- Kenya > Western Province (0.04)
- South Africa (0.04)
- Botswana (0.04)
- The Gambia (0.04)
- Nigeria (0.04)
- Ghana (0.04)
- Eswatini (0.04)
- Namibia (0.04)
- Middle East
- Zimbabwe (0.04)
- Eritrea (0.04)
- Rwanda (0.04)
- Mozambique (0.04)
- Uganda (0.04)
- Gabon (0.04)
- Tanzania (0.04)
- South Sudan (0.04)
- Madagascar (0.04)
- Malawi (0.04)
- Liberia (0.04)
- Angola (0.04)
- Senegal (0.04)
- Cameroon (0.04)
- Burundi (0.04)
- Guinea-Bissau (0.04)
- Mauritius (0.04)
- Comoros (0.04)
- Benin (0.04)
- Chad (0.04)
- Zambia (0.04)
- Côte d'Ivoire (0.04)
- Asia
- Pakistan (0.04)
- Cambodia (0.04)
- Nepal (0.04)
- Mongolia (0.04)
- Malaysia (0.04)
- Kazakhstan (0.04)
- Uzbekistan (0.04)
- Bhutan (0.04)
- Azerbaijan (0.04)
- Vietnam (0.04)
- Indonesia (0.04)
- Middle East
- Philippines (0.04)
- Timor-Leste (0.04)
- Armenia (0.04)
- Sri Lanka (0.04)
- Thailand (0.04)
- Singapore (0.04)
- Tajikistan (0.04)
- India (0.04)
- Afghanistan (0.04)
- Europe
- Albania (0.04)
- Belarus (0.04)
- Germany > Bavaria
- Upper Bavaria > Munich (0.04)
- Moldova (0.04)
- Serbia (0.04)
- Switzerland > Zürich
- Zürich (0.14)
- Ukraine (0.04)
- United Kingdom > England
- Cambridgeshire > Cambridge (0.04)
- North America
- Cuba (0.04)
- Haiti (0.04)
- El Salvador (0.04)
- Jamaica (0.04)
- Mexico (0.04)
- Guatemala (0.04)
- Nicaragua (0.04)
- Belize (0.04)
- Honduras (0.04)
- Dominican Republic (0.04)
- United States > New York (0.04)
- Costa Rica (0.04)
- Panama (0.04)
- Oceania
- Fiji (0.04)
- Papua New Guinea (0.04)
- South America
- Africa
- Genre:
- Research Report
- Experimental Study (1.00)
- New Finding (1.00)
- Research Report
- Industry:
- Health & Medicine > Therapeutic Area
- Immunology > HIV (1.00)
- Infections and Infectious Diseases (1.00)
- Health & Medicine > Therapeutic Area
- Technology: